World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
55933
World Ranking
4038
National Ranking
2213

Keith L. Ligon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keith L. Ligon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,011 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keith L. Ligon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keith L. Ligon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Keith L. Ligon is affiliated with Harvard University in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, contributing extensively to understanding cancer biology and related areas.

The main topics covered in their work include:

  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Neuroblastoma Research and Treatments
  • Single-cell and Spatial Transcriptomics
  • Cancer, Hypoxia, and Metabolism
  • Cancer Research and Treatments

Ligon has published in notable venues, with frequent contributions to:

  • Neuro-Oncology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Neuro-Oncology Advances

Among their recent scientific papers are:

  • Mechanisms and therapeutic implications of hypermutation in gliomas, 2020, Nature
  • Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis, 2021, Cell
  • A pathology foundation model for cancer diagnosis and prognosis prediction, 2024, Nature
  • A molecularly integrated grade for meningioma, 2021, Neuro-Oncology
  • Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions, 2022, Neuro-Oncology

Their collaborative work frequently involves co-authors such as:

  • Patrick Y. Wen
  • Pratiti Bandopadhayay
  • Rameen Beroukhim
  • David A. Reardon
  • Wenya Linda Bi

Ligon's research emphasizes genetic and molecular mechanisms underpinning cancer, especially gliomas and other brain tumors. Their involvement in molecular biology and genetics is reflected in a substantial number of publications addressing cancer genomics and diagnostics.

Their contributions include investigations using advanced methodologies such as single-cell transcriptomics and machine learning in medical imaging, reflecting interdisciplinary approaches linking molecular biology with computational techniques.

Best Publications

  • Malignant astrocytic glioma: genetics, biology, and paths to treatment.

    Frank B. Furnari;Tim Fenton;Robert M. Bachoo;Akitake Mukasa

  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Cyril Neftel;Julie Laffy;Mariella G. Filbin;Toshiro Hara

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies

    Jayne M. Stommel;Alec C. Kimmelman;Haoqiang Ying;Roustem Nabioullin

  • p16INK4a induces an age-dependent decline in islet regenerative potential.

    Janakiraman Krishnamurthy;Matthew R. Ramsey;Keith L. Ligon;Chad Torrice

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill

  • p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

    Hongwu Zheng;Haoqiang Ying;Haiyan Yan;Alec C. Kimmelman

  • Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

    Robert M Bachoo;Elizabeth A Maher;Keith L Ligon;Norman E Sharpless

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

    Yoon Jae Cho;Aviad Tsherniak;Pablo Tamayo;Sandro Santagata

  • Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.

    Ulrich Schüller;Vivi M. Heine;Vivi M. Heine;Junhao Mao;Alvin T. Kho

  • Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

    Mariella G. Filbin;Itay Tirosh;Itay Tirosh;Volker Hovestadt;Volker Hovestadt;McKenzie L. Shaw;McKenzie L. Shaw

  • Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

    Priscilla K Brastianos;Peleg M Horowitz;Sandro Santagata;Sandro Santagata;Robert T Jones

  • Emerging insights into the molecular and cellular basis of glioblastoma

    Gavin P. Dunn;Mikael L. Rinne;Mikael L. Rinne;Jill Wykosky;Giannicola Genovese

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination

    Ben Emery;Dritan Agalliu;John D. Cahoy;Trent A. Watkins

  • Targetable genetic features of primary testicular and primary central nervous system lymphomas

    Bjoern Chapuy;Margaretha G. M. Roemer;Margaretha G. M. Roemer;Chip Stewart;Yuxiang Tan

  • Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

    Keith L. Ligon;Emmanuelle Huillard;Emmanuelle Huillard;Shwetal Mehta;Santosh Kesari

  • Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

    Nicholas Butowski;Howard Colman;John F. De Groot;Antonio M. Omuro

  • Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity.

    Jessian L Munoz;Sarah A Bliss;Steven J Greco;Shakti H Ramkissoon;Shakti H Ramkissoon

Frequent Co-Authors

Rameen Beroukhim
Rameen Beroukhim Harvard University
Patrick Y. Wen
Patrick Y. Wen Harvard University
David A. Reardon
David A. Reardon Harvard University
Sandro Santagata
Sandro Santagata Brigham and Women's Hospital
Mark W. Kieran
Mark W. Kieran Harvard University
Brian M. Alexander
Brian M. Alexander Foundation Medicine
Azra H. Ligon
Azra H. Ligon Brigham and Women's Hospital
William C. Hahn
William C. Hahn Dana-Farber Cancer Institute
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
E. Antonio Chiocca
E. Antonio Chiocca Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare career options in the USA extends beyond the traditional path to becoming a physician. Several adn to fnp bridge programs allow registered nurses with an associate degree to advance their qualifications online, moving toward roles such as Family Nurse Practitioner.

For those interested in nutrition and wellness, pursuing an online bachelor's degree in nutrition can open doors to careers in dietetics, food research, or health education. These flexible programs make it easier to balance work, study, and family life.

Healthcare administration is another vital field. Accredited programs like cahme accredited mha online programs prepare graduates for leadership roles in hospitals and health systems, with emphasis on health policy, business skills, and management.

Nursing professionals looking to further their expertise can consider online rn to bsn programs without clinicals, which focus on advanced nursing theory and evidence-based care, without the need for additional in-person clinicals.

Best Scientists Citing Keith L. Ligon

Trending Scientists

Recently Published Articles